Cell Processing Instruments Market Report 2026

Cell Processing Instruments Market Overview

• Cell Processing Instruments market size has reached to $6.95 billion in 2025 • Expected to grow to $10.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Increasing Investment In Biopharmaceutical Research Is Fueling The Growth Of The Market Due To Rising Demand For Advanced And Scalable Cell-Based Therapy Development • Market Trend: Technological Innovations Like Multi-Channel Asynchronous Processing Are Driving Advances in Single-Cell Analysis Workflows • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Processing Instruments Market?

Cell processing instruments are specialized equipment designed for the controlled handling of cells in laboratory and production environments. They are engineered to maintain accuracy, sterility, and consistency while supporting the preparation of cells under standardized conditions. These instruments are built with advanced features to ensure high-quality performance, reliability, and compliance with regulatory and safety standards. The main types of cell processing instruments include cell counters, cell imaging systems, flow cytometers, cell separator systems, automated cell processing systems, and others. Cell counters are devices used to count the number of cells in a sample accurately and rapidly. It is applied for cell isolation or separation, cell imaging and counting, cell viability and proliferation, and others, and caters to several end uses such as pharmaceutical and biotechnology companies, contract research organizations (CROs) and contract manufacturing organizations (CMOs), academic and research institutes, and others.

What Is The Cell Processing Instruments Market Growth Forecast?

The cell processing instruments market size is expected to see strong growth in the next few years. It will grow to $10.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of integrated cell processing platforms, rising investment in cell therapy and regenerative medicine, adoption of digital and automated imaging systems, increasing contract research and manufacturing activities, advancements in live cell analysis and high-content screening. Major trends in the forecast period include rising demand for automated cell processing systems, increasing adoption of flow cytometry and high-content imaging, growth in cell therapy and regenerative medicine applications, emphasis on standardization and regulatory compliance, integration of multi-functional cell analysis platforms.

Global Cell Processing Instruments Market Segmentation

1) By Type: Cell Counters, Cell Imaging Systems, Flow Cytometers, Cell Separator Systems, Automated Cell Processing Systems, Other Instruments 2) By Application: Cell Isolation Or Separation, Cell Imaging And Counting, Cell Viability And Proliferation, Other Applications 3) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs), Academic And Research Institutes, Other End-Uses Subsegments: 1) By Cell Counters: Manual Cell Counters, Automated Cell Counters, Digital Cell Counters 2) By Cell Imaging Systems: Brightfield Imaging Systems, Fluorescence Imaging Systems, High-Content Imaging Systems, Live Cell Imaging Systems 3) By Flow Cytometers: Analog Flow Cytometers, Digital Flow Cytometers, Benchtop Flow Cytometers, Clinical Flow Cytometers 4) By Cell Separator Systems: Magnetic-Activated Cell Sorting (MACS) Systems, Fluorescence-Activated Cell Sorting (FACS) Systems, Centrifugal Elutriation Systems 5) By Automated Cell Processing Systems: Cell Expansion Systems, Cell Washing And Concentration Systems, Cell Harvesting Systems, Integrated Cell Processing Platforms 6) By Other Instruments: Cell Disruption Systems, Cell Viability Analyzers, Centrifuges For Cell Processing, Cell Freezing And Thawing Systems

What Is The Driver Of The Cell Processing Instruments Market?

The increasing investment in biopharmaceutical research is expected to propel the growth of the cell processing instruments market going forward. Biopharmaceutical research refers to the scientific study and development of therapeutic products derived from biological sources or designed to mimic biological molecules for diagnosing, preventing, or treating diseases. Increasing investment in biopharmaceutical research is due to growing demand for innovative therapies to address rising chronic diseases and unmet medical needs, prompting greater research and development efforts for targeted, effective treatments. Cell processing instruments support biopharmaceutical research by enabling efficient, standardized, and scalable cell handling, which accelerates the development and production of advanced cell-based therapies. For instance, in January 2025, according to the BioIndustry Association (BIA), a UK-based trade association, the UK biotech sector experienced substantial growth in 2024, securing £3.5 billion (approximately $ 4.4 billion) in investment, an impressive 94% incrDIGITease from the previous year. Therefore, the increasing investment in biopharmaceutical research is driving the growth of the cell processing instruments industry.

Key Players In The Global Cell Processing Instruments Market

Major companies operating in the cell processing instruments market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Avantor Inc., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Takara Bio Inc., 10x Genomics Inc., Promega Corporation, Esco Lifesciences Group Ltd., NanoCellect Biomedical Inc., InGeneron Inc.

Global Cell Processing Instruments Market Trends and Insights

Major companies operating in the cell processing instruments market are focusing on developing innovative approaches, such as multi-channel asynchronous processing, to enhance workflow efficiency and flexibility in cell therapy development. Multi-channel asynchronous processing is the ability of a system to run multiple independent workflows simultaneously on separate channels, allowing different processes to operate in parallel without waiting for each other to complete. For instance, in June 2023, Singleron Biotechnologies GmbH, a Germany-based biotechnology company, launched two new instruments, Python Junior and Matrix NEO, to enhance and standardize the single-cell analysis workflow. Python Junior streamlines the dissociation of solid tissues into high-quality single-cell suspensions using dual independent channels and a mix of mechanical and enzymatic processing, while Matrix NEO enables high-throughput, fully automated single-cell library preparation with chip priming, cell partitioning, lysis, and nucleic acid capture across four channels, supporting diverse applications and throughput levels in both research and clinical settings.

What Are Latest Mergers And Acquisitions In The Cell Processing Instruments Market?

In February 2023, Cytek Biosciences, a US-based life sciences company, acquired the flow cytometry imaging business from DiaSorin for an undisclosed amount. Through this acquisition, Cytek Biosciences aims to expand its global footprint and enhance its cell analysis offerings by integrating Luminex’s Flow Cytometry and Imaging business unit, including its technologies, talent, and established customer base. DiaSorin S.p.A. is an Italy-based company that manufactures cell processing instruments.

Regional Outlook

North America was the largest region in the cell processing instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cell Processing Instruments Market?

The cell processing instruments market consists of sales of centrifuges, microfluidic cell processors, single-use tubing and connectors, sterile filling, and sealing equipment. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.